Direct Answer
Pathology billing is built on a specimen-centric model where the primary coding unit is the gross and microscopic examination of a tissue specimen. Surgical pathology codes (88300-88309) are assigned by the level of examination complexity for each separately submitted specimen. The most impactful billing decision in pathology is correctly assigning the surgical pathology level — which is determined by the specific organ/tissue type and the examination complexity, not by the diagnosis. Beyond surgical pathology, immunohistochemistry, molecular diagnostics, and flow cytometry add significant revenue that requires its own documentation and compliance infrastructure.
Table of Contents
Surgical Pathology Levels 88300-88309
Surgical pathology codes are billed per specimen submitted, with the level determined by examination complexity: Level I — 88300: gross examination only; specimens that by their nature and absence of any clinical information do not require microscopic examination (e.g., foreskin from circumcision of a child, teeth, tonsils when no clinical concern); Level II — 88302: gross and microscopic examination; requires microscopic examination but only standard: appendix incidental (no symptoms), fallopian tube sterilization, vas deferens sterilization, hernia sac, hydrocele sac, skin — plastic repair; Level III — 88304: requires a slightly more detailed examination: abortion material (curettings), cholecystectomy specimens, cyst (pilonidal), ganglion cyst, laryngoscopy specimens, meniscus, nasal polyps, patella with degenerative disease, skin — cyst/tag, soft tissue lesion (lipoma); Level IV — 88305: most common level in clinical practice; includes: appendix (clinical diagnosis of appendicitis), bone marrow biopsy, cervical biopsy, colon polyp, endometrium biopsy, kidney biopsy, larynx partial resection, lung transbronchial biopsy, nerve biopsy, prostate needle biopsy, skin excision (not plastic repair), small intestine biopsy, synovium, uterine contents; Level V — 88307: complex resection specimens: breast biopsy (not excision), colon segment (not for tumor), esophagus partial resection, gallbladder for cholecystitis, kidney partial/total nephrectomy for non-tumor, larynx total resection (non-tumor), lung lobe, ovary with/without tube (non-neoplastic), placenta (third trimester), prostate (TURP specimen), uterus myomectomy; Level VI — 88309: most complex; requires the greatest examination effort: colon resection for tumor, pancreaticoduodenectomy (Whipple), stomach partial/total resection for tumor, thyroid total resection, bladder total resection, rectum resection for tumor, uterus (other than fibroid); Multiple specimens: each separately submitted and labeled specimen receives its own surgical pathology code; a single surgical procedure submitting 3 specimens (e.g., right colon, left colon, small bowel — each labeled separately): bill 3 separate surgical pathology codes based on the level appropriate to each specimen.
Immunohistochemistry and Special Stains
Immunohistochemistry (IHC) and special stains add significant revenue to surgical pathology: IHC codes: 88342 — immunohistochemistry or immunocytochemistry (IHC); per specimen; initial single antibody stain procedure; 88341 — each additional single antibody stain procedure; 88344 — each multiplex antibody stain procedure; What these codes cover: each antibody stain applied to the surgical pathology specimen; each antibody application is separately billable; example: a colon biopsy specimen (88305) with IHC staining for CDX2, CK20, CK7, and TTF-1 = 88342 (initial) + 88341 + 88341 + 88341 (3 additional) = 4 codes; Medical necessity for IHC: Medicare and commercial payers require that IHC staining be medically necessary for diagnosis; protocols that reflexively apply IHC panels to all specimens of a given type without individualized medical necessity may be subject to denial; documentation in the pathology report should describe: the clinical question the IHC addresses; the specific antibodies selected and their diagnostic relevance; the interpretation of each stain in the context of the overall diagnosis; Special stains (histochemical): 88312 — special stain including interpretation and report; Group I (5 or more stains): usually for organisms (AFB, GMS, PAS); 88313 — Group II: other than organisms (Masson trichrome, Alcian blue, etc.); 88314 — histochemical stain on frozen tissue block; Per specimen: 88312-88314 are billed per specimen, not per stain; Flow cytometry: 88184 — flow cytometry, cell surface, cytoplasmic, or nuclear marker; technical component; first marker; 88185 — each additional marker; 88187-88189 — professional component interpretation; used for lymphoma/leukemia immunophenotyping.
Cytopathology and Pap Smear Coding
Cytopathology covers examination of cells from body fluids, washings, brushings, and smears: Cervical cytology (Pap smear) codes: 88141 — cytopathology, cervical or vaginal; requiring interpretation by physician; 88142 — ThinPrep (liquid-based, monolayer); 88143 — ThinPrep with manual rescreening; 88150 — conventional Pap smear; 88164-88167 — automated with manual rescreening, various methods; 88174 — automated thin layer preparation; 88175 — automated with rescreening; HPV testing: 87624 — infectious agent detection by nucleic acid; Human Papillomavirus, high-risk types; 87625 — types 16 and 18 only; HPV testing is separately billable from the Pap smear; Non-gynecologic cytology: 88160 — cytopathology, smears, any other source; screening and interpretation; 88161 — preparation, screening, and interpretation; 88162 — extended study involving more than 5 slides; Fine needle aspiration cytology: 88172 — cytopathology, evaluation of fine needle aspirate; immediate cytosmears; 88173 — interpretation and report; 88177 — immediate cytosmear interpretation (additional during same encounter); Body fluid cytology: 88104 — washings or brushings except bronchopulmonary; 88106 — simple filter method; 88107 — filter transfer, other than fluids; 88108 — concentration technique, smears and interpretation; Sputum: 88104 — sputum specimen; urine cytology: 88108 (concentration technique).
Molecular Pathology and Genomic Testing
Molecular pathology is the fastest-growing segment of pathology billing: Tier 1 molecular pathology codes (81161-81408): Tier 1 codes are analyte-specific codes for commonly ordered molecular tests; examples: BRCA1 and BRCA2: 81162 (full sequence) or 81163/81164/81165 (individual variants); KRAS: 81275 (variants in codons 12, 13, 61); EGFR: 81235; BRAF V600: 81210; JAK2: 81270; Factor V Leiden: 81240; prothrombin G20210A: 81240; hereditary hemochromatosis HFE: 81256; fragile X: 81243; huntington: 81271; Tier 2 molecular pathology codes (81400-81408): Tier 2 codes are gene-specific for less commonly ordered tests; organized by analysis complexity (81400 = tier 2, level 1 through 81408 = tier 2, level 9); the appropriate tier 2 code is selected based on the gene being analyzed and the type of analysis (sequencing, deletion/duplication analysis, etc.); Multianalyte assay with algorithmic analysis (MAAA): genomic profiling tests that analyze multiple analytes and incorporate an algorithm: Oncotype DX (breast cancer): 81519; MammaPrint: 81523; Oncotype DX colon: 81525; Decipher Prostate: 0111U (PLA code); Foundation Medicine CDx: 81455 (solid tumor, 5-50 genes) or applicable multi-gene panel code; Proprietary Laboratory Analyses (PLA) codes: unique codes for specific, branded laboratory tests; examples: 0021U (Oncotype DX DCIS); 0111U (Decipher Prostate); PLA codes are published quarterly by the AMA.
Pathology Denials and RCM
Pathology billing denials concentrate in IHC medical necessity, molecular test coverage, and specimen coding accuracy: Common pathology denial patterns: IHC panel without medical necessity documentation: applying a standard IHC panel without documenting the clinical question and antibody selection rationale; payers review IHC claims for reflexive panel billing vs. individualized testing; wrong surgical pathology level: assigning a lower level than the specimen warrants (under-coding) or assigning a higher level than supported by the specimen type (over-coding); the CPT manual includes a specimen list for each level — use it; molecular test NCD/LCD coverage not met: many molecular tests (NGS panels, hereditary cancer panels) have specific NCD or LCD coverage criteria; billing without meeting and documenting the criteria results in denial; BRCA testing without documentation of indication (personal breast/ovarian cancer diagnosis or qualifying family history) is a common example; Pathology RCM best practices: surgical pathology level assignment policy: maintain a written policy that maps each specimen type to the appropriate CPT level based on the AMA CPT specimen list; coders should use this matrix for consistent level assignment; IHC medical necessity documentation standard: require the pathologist to document the clinical question, antibody selection rationale, and staining results in the pathology report; this documentation is the medical necessity support for the IHC codes; molecular test coverage pre-check: before performing molecular tests (especially NGS panels, hereditary cancer panels), verify the patient's payer and the specific coverage criteria; advance beneficiary notice (ABN) for Medicare patients when coverage is uncertain prevents uncollectable bad debt.
FAQ
How should a pathology group bill when multiple specimens from the same surgery are submitted — can they all be billed at the same CPT code?
Multiple specimens from a single surgery are billed separately — each submitted specimen receives its own surgical pathology code based on that specimen's examination level: The per-specimen rule: the surgical pathology codes 88300-88309 are billed per specimen submitted, not per patient or per surgery; a colectomy for colon cancer submitted as 4 separately labeled specimens (proximal margin, distal margin, colon segment with tumor, 3 lymph nodes together): each specimen receives its own code; Code assignment by specimen type: proximal margin — colon segment: 88309; distal margin — colon segment: 88309; colon segment with tumor: 88309; lymph nodes (3 together as one submitted specimen): 88307; When can multiple specimens use the same code: if multiple anatomically similar specimens are submitted in the same container under one label (e.g., "polyp fragments, site 1"), they are one specimen and receive one code; if the same type of specimen is submitted as separate separately labeled items (e.g., "polyp site 1" and "polyp site 2"), each receives its own code; Multiple specimens from one organ: a colonoscopy submitting 5 separately labeled colon polyps (sites 1-5) = 5 separate 88305 codes; this is not unbundling — it is the appropriate per-specimen billing; Modifier 59: when billing multiple units of the same CPT code for separate specimens, many payers and clearinghouses require Modifier 59 (distinct procedural service) on the second and subsequent specimens of the same code to indicate each is a distinct, separate specimen; some practices use X-modifiers (XE, XS, XP, XU) as the more specific subset of Modifier 59; Payer policies: some commercial payers have policies that limit payment to a certain number of units per procedure per date regardless of specimen count; understanding per-payer policies is important for maximizing collection and appeal strategy.
What is the difference between Tier 1 and Tier 2 molecular pathology codes and how should labs select between them?
The molecular pathology CPT coding structure uses two tiers that differ in their analyte specificity and level of complexity: Tier 1 codes (81161-81408): Tier 1 codes are analyte-specific — each code identifies a specific gene, mutation, or test; they are reserved for tests that are commonly ordered and have sufficient volume to merit their own dedicated code; when a Tier 1 code exists for the specific test being performed, the Tier 1 code must be used; examples of Tier 1: KRAS codon 12, 13 mutation analysis: 81275; EGFR common variants: 81235; BRCA1 full sequence analysis: 81162; JAK2 mutation: 81270; BCR/ABL translocation: 81206-81208; how to identify: if the specific gene and type of analysis has a dedicated CPT code in the 81161-81408 range, that code must be used; Tier 2 codes (81400-81408): Tier 2 codes are for molecular tests not separately listed in Tier 1; organized by the level of analytical complexity: 81400 — Level 1 (simplest); 81401 — Level 2; through 81408 — Level 9 (most complex); the appropriate tier 2 level is determined by: the gene being analyzed; the type of analysis (common duplication/deletion analysis = lower level; full gene sequencing with deletion/duplication analysis = higher level; pharmacogenomics panels = varies); CMS and the AMA publish a mapping document that lists specific genes and analysis types under each tier 2 level; When neither Tier 1 nor Tier 2 applies: for novel or emerging molecular tests not captured by either tier, the unlisted molecular pathology code (81479) may be used; unlisted codes require special documentation explaining the test performed and the medical necessity; many laboratories use 81479 for emerging biomarkers before a specific CPT code is established; Key error: using a Tier 2 code when a Tier 1 code exists — this is incorrect and may be considered miscoding; always check the Tier 1 code list first before assigning a Tier 2 code.
Pathology Revenue Cycle Management Built for Specimen Complexity
Valiant Lifecare's pathology billing specialists manage surgical pathology level assignment by specimen type, IHC code 88342-88344 medical necessity documentation, cytopathology and Pap smear coding, Tier 1 and Tier 2 molecular pathology code selection, NGS panel coverage criteria, flow cytometry billing, and the full spectrum of pathology denial prevention — ensuring your laboratory captures full reimbursement for every specimen and test performed.
Optimize Your Pathology Revenue Cycle